Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Adomeglivant (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms PX-GRA
- 21 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Aug 2017.
- 27 Nov 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2016.
- 02 Nov 2016 New trial record